could glp-1 be the next mental health drug Receptor Agonists in Mood Disorders: A Psychiatric Perspective Could GLP-1 drugs help your

"Public Health"

GLP-1 receptor agonists have already shown promise in reducing inflammation, oxidative stress, and neuronal damage, which are key factors in neurodegenerative diseases, Diana Thiara, MD , assistant clinical professor of medicine at the University of California, San Francisco, said in a related editorial

Exenatide injection

4 Discussion In conclusion, we found significant over-representation of signals for acute pancreatitis (SMQ: 20000022) over other adverse reactions for all GLP-1 RAs

Cardiovascular Benefits Clinical trials show cardiovascular risk reduction in patients with metabolic syndromebenefits beyond just weight loss

Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and couterregulation during hypoglycemia